Intuitive Surgical Inc
ISRG: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$943.00 | Qpt | Rcvjxjtwm |
No Further Surprises in Intuitive’s Fourth Quarter
Having already prereleased its fourth-quarter results, Intuitive’s announcement on Jan. 20 wasn’t particularly surprising. The company’s 2022 procedure growth guidance of 11%-15% is conservative and reflects uncertainty around hospital capacity. We maintain our valuation and wide moat rating on the company.